Axcelis Technologies Q1 2026 Earnings Call Insights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy ACLS?
Source: seekingalpha
- Financial Performance Exceeds Expectations: Axcelis reported Q1 2026 revenue of $199 million and earnings per diluted share of $0.72, slightly above expectations, despite a one-time $5 million customer settlement impact, demonstrating resilience in the market.
- System Shipment Growth: While CS&I revenue moderated sequentially, it grew over 30% year-over-year, and system shipments to the memory market reached their highest level since Q4 2023, indicating strong demand in key markets.
- Optimistic Future Outlook: The company expects Q2 revenue of approximately $205 million with gross margins around 43% and estimated net earnings per diluted share of about $0.90, reflecting confidence in revenue growth in the second half, particularly in silicon carbide.
- Merger Progressing Smoothly: The merger with Veeco is anticipated to close in the second half of 2026, with the only remaining approval being regulatory clearance in China, highlighting positive strategic integration efforts.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ACLS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ACLS
Wall Street analysts forecast ACLS stock price to fall
3 Analyst Rating
1 Buy
1 Hold
1 Sell
Hold
Current: 158.660
Low
94.00
Averages
99.67
High
105.00
Current: 158.660
Low
94.00
Averages
99.67
High
105.00
About ACLS
Axcelis Technologies, Inc. provides high-productivity solutions for the semiconductor industry. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the critical and enabling steps in the IC manufacturing process. Its ion implantation products include high current ion implant, high energy ion implant and medium current ion implant. The Company's Purion H, Purion Dragon, Purion H200, and GSD/E2 Ovation spot beam, high current systems cover all traditional high current requirements as well as those associated with emerging and future devices. Its Purion XE, EXE, and other Purion high energy systems combine its production-proven RF Linac high energy, spot beam technology with the Purion platform wafer handling system. Its medium current ion implant products include its Purion M Si and SiC medium current systems. It also offers its customers aftermarket service and support.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Financial Performance Exceeds Expectations: Axcelis reported Q1 2026 revenue of $199 million and earnings per diluted share of $0.72, slightly above expectations, despite a one-time $5 million customer settlement impact, demonstrating resilience in the market.
- System Shipment Growth: While CS&I revenue moderated sequentially, it grew over 30% year-over-year, and system shipments to the memory market reached their highest level since Q4 2023, indicating strong demand in key markets.
- Optimistic Future Outlook: The company expects Q2 revenue of approximately $205 million with gross margins around 43% and estimated net earnings per diluted share of about $0.90, reflecting confidence in revenue growth in the second half, particularly in silicon carbide.
- Merger Progressing Smoothly: The merger with Veeco is anticipated to close in the second half of 2026, with the only remaining approval being regulatory clearance in China, highlighting positive strategic integration efforts.
See More
- Stock Performance: Axcelis Technologies (ACLS) closed at $143.13, reflecting a 2.34% increase from the previous day, outperforming the S&P 500's daily gain of 0.8%, indicating strong performance in the semiconductor services sector.
- Monthly Gain: Over the past month, Axcelis's stock has surged by 42.21%, significantly exceeding the Computer and Technology sector's gain of 12.05% and the S&P 500's 8.11%, reflecting optimistic market expectations for its future growth.
- Earnings Expectations: Axcelis is set to release its earnings report on May 7, 2026, with projected earnings per share (EPS) of $0.71, a 31.73% decrease year-over-year, but quarterly revenue is expected to reach $195.05 million, up 1.29%, indicating potential revenue growth.
- Valuation Analysis: Currently, Axcelis trades at a forward P/E ratio of 39.51, below the industry average of 40.35, suggesting its stock may be undervalued, while a PEG ratio of 13.48 indicates high expectations for future earnings growth, warranting investor attention to its industry ranking and market performance.
See More

Company Acquisition: Acelist Technologies is set to acquire Neutral, indicating a strategic move in the tech industry.
Target Price Increase: Acelist has raised its target price to $150 from $91, reflecting increased confidence in its market position.
See More
- Conference Sponsorship: Axcelis Technologies announced its role as the Diamond Sponsor for the 2026 Compound Semiconductor Asia Conference, taking place from March 24-27 in Shanghai, which reinforces its leadership position in the semiconductor industry and enhances its market influence.
- CEO Keynote Speech: President and CEO Russell Low, PhD, will deliver the opening keynote speech at the conference, sharing insights on the company's innovations in ion implantation solutions, which is expected to attract significant attention from industry participants and elevate the company's brand recognition.
- Technology Innovation Showcase: The company will also introduce its next-generation Purion Power Series+ platform, aimed at meeting the demands of Chinese chipmakers for high-performance semiconductor solutions, thereby driving the global demand for clean energy solutions.
- Industry Leadership: With over 45 years of experience in ion implantation systems, Axcelis is dedicated to providing high-productivity solutions for the semiconductor industry, further solidifying its position as an innovator and leader in the global market.
See More
- Executive Change: Hexcel Corporation announced the appointment of James Coogan as Chief Financial Officer effective May 1, succeeding Mike Lenz, who served as interim CFO, indicating the company's commitment to stable financial management.
- Extensive Experience: Coogan most recently served as CFO at Axcelis Technologies and previously held the same position at Kaman Corporation, bringing valuable financial strategic insights from the semiconductor and aerospace sectors to Hexcel.
- Strategic Implications: This appointment aims to strengthen Hexcel's financial leadership, particularly as the aerospace industry faces both challenges and opportunities, ensuring the company can effectively navigate market changes and drive growth.
- Transition Management: During Lenz's tenure as interim CFO, Hexcel maintained financial stability, and Coogan's onboarding will facilitate a smooth transition, ensuring consistency and coherence in the company's future financial decisions.
See More










